Manifaxine
Alternative Names: 1555; 1555U88; BW 1555U88; GW 320659; Manifaxina; ManifaxinumLatest Information Update: 16 Aug 2023
At a glance
- Originator GlaxoSmithKline
- Class Antidepressants; Small molecules; Smoking cessation therapies
- Mechanism of Action Adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Attention-deficit hyperactivity disorder; Obesity; Smoking withdrawal
Most Recent Events
- 25 Feb 2003 Discontinued - Phase-II for Obesity in USA (unspecified route)
- 14 Nov 2002 Discontinued - Phase-II for Attention-deficit hyperactivity disorder in United Kingdom (unspecified route)
- 14 Nov 2002 Discontinued - Phase-II for Attention-deficit hyperactivity disorder in USA (unspecified route)